Literature DB >> 12958450

Live viral vectors: Semliki Forest virus.

Gunilla B Karlsson1, Peter Liljeström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12958450     DOI： 10.1385/1-59259-399-2:69

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  15 in total

1.  Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling.

Authors:  Asa S Hidmark; Eva K L Nordström; Pia Dosenovic; Mattias N E Forsell; Peter Liljeström; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.

Authors:  Maria Lisa Knudsen; Karl Ljungberg; Maria Kakoulidou; Linda Kostic; David Hallengärd; Juan García-Arriaza; Andres Merits; Mariano Esteban; Peter Liljeström
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts.

Authors:  Iyadh Douagi; Gerald M McInerney; Asa S Hidmark; Vassoula Miriallis; Kari Johansen; Lennart Svensson; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

4.  Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.

Authors:  Asa S Hidmark; Gerald M McInerney; Eva K L Nordström; Iyadh Douagi; Kristen M Werner; Peter Liljeström; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus.

Authors:  Mattias N E Forsell; Yuxing Li; Maria Sundbäck; Krisha Svehla; Peter Liljeström; John R Mascola; Richard Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Viral alteration of cellular translational machinery increases defective ribosomal products.

Authors:  Peter Berglund; Diana Finzi; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

7.  Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.

Authors:  Petra Mooij; Sunita S Balla-Jhagjhoorsingh; Niels Beenhakker; Patricia van Haaften; Ilona Baak; Ivonne G Nieuwenhuis; Shirin Heidari; Hans Wolf; Marie-Joelle Frachette; Kurt Bieler; Neil Sheppard; Alexandre Harari; Pierre-Alexandre Bart; Peter Liljeström; Ralf Wagner; Giuseppe Pantaleo; Jonathan L Heeney
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.

Authors:  Andreas Mörner; Iyadh Douagi; Mattias N E Forsell; Christopher Sundling; Pia Dosenovic; Sijy O'Dell; Barna Dey; Peter D Kwong; Gerald Voss; Rigmor Thorstensson; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

9.  The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon.

Authors:  Maria L Knudsen; Daniel X Johansson; Linda Kostic; Eva K L Nordström; Karin Tegerstedt; Anna Pasetto; Steven E Applequist; Karl Ljungberg; Jean-Claude Sirard; Peter Liljeström
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

10.  Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus.

Authors:  Kristi Tamm; Andres Merits; Inga Sarand
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.